Arbutus Biopharma (ABUS) Reports Q1 Loss of $0.36/Share

Arbutus Biopharma (NASDAQ: ABUS) reported Q1 EPS of ($0.36), versus ($0.34) reported last year. Revenue for the quarter came in at $1.4 thousand, versus $200 million reported last year.

For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.

You May Also Be Interested In

• Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics